These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1191314)

  • 1. Reduction in binding of [14C] aflatoxin B1 to rat liver macromolecules by phenobarbitone pretreatment.
    Garner RC
    Biochem Pharmacol; 1975 Aug; 24(16):1553-6. PubMed ID: 1191314
    [No Abstract]   [Full Text] [Related]  

  • 2. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of [-14C]aflatoxin B1 to cellular macromolecules in the rat and hamster.
    Garner RC; Wright CM
    Chem Biol Interact; 1975 Aug; 11(2):121-31. PubMed ID: 1139740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of phenobarbital pretreatment on the metabolism, covalent binding, and cytotoxicity of aflatoxin B1 in primary cultures of rat hepatocytes.
    Loury DJ; Hsieh DP; Byard JL
    J Toxicol Environ Health; 1984; 13(1):145-59. PubMed ID: 6201621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,3-Dihydro-2-(guan-7-yl)-3-hydroxy-aflatoxin B1, a major acid hydrolysis product of aflatoxin B1-DNA or -ribosomal RNA adducts formed in hepatic microsome-mediated reactions and in rat liver in vivo.
    Lin JK; Miller JA; Miller EC
    Cancer Res; 1977 Dec; 37(12):4430-8. PubMed ID: 922734
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro metabolic conversion of aflatoxins and benzo(alpha)pyrene to nucleic acid-binding metabolites.
    Gurtoo HL; Dave CV
    Cancer Res; 1975 Feb; 35(2):382-9. PubMed ID: 234034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of aflatoxin B1 and aflatoxin G1 binding to cellular macromolecules in vitro, in vivo and after peracid oxidation; characterisation of the major nucleic acid adducts.
    Garner RC; Martin CN; Smith JR; Coles BF; Tolson MR
    Chem Biol Interact; 1979 Jun; 26(1):57-73. PubMed ID: 466744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of pre-treatment with phenobarbitone on the activation of aflatoxin B1 by rat liver.
    Neal GE; Godoy HM
    Chem Biol Interact; 1976 Aug; 14(3-4):279-89. PubMed ID: 954146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of neonatal phenobarbital exposure on aflatoxin b1 disposition in adult rats.
    Faris RA; Campbell TC
    Cancer Res; 1983 Jun; 43(6):2576-83. PubMed ID: 6406048
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro metabolism of aflatoxin B1 by rat liver nuclei.
    Vaught JB; Klohs W; Gurtoo HL
    Life Sci; 1977 Nov; 21(10):1497-504. PubMed ID: 927012
    [No Abstract]   [Full Text] [Related]  

  • 11. A mechanism of inhibition of aflatoxin B1-DNA binding in the liver by phenobarbital pretreatment of rats.
    Lotlikar PD; Raj HG; Bohm LS; Ho LL; Jhee EC; Tsuji K; Gopalan P
    Cancer Res; 1989 Feb; 49(4):951-7. PubMed ID: 2492210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolism of aflatoxin B1 by hepatocytes isolated from rats following the in vivo administration of some xenobiotics.
    Metcalfe SA; Neal GE
    Carcinogenesis; 1983 Aug; 4(8):1007-12. PubMed ID: 6409441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some high-performance liquid-chromatographic studies of the metabolism of aflatoxins by rat liver microsomal preparations.
    Neal GE; Colley PJ
    Biochem J; 1978 Sep; 174(3):839-51. PubMed ID: 728090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic exposure to aflatoxin B1 and aflatoxin M1 on the in vivo covalent binding of aflatoxin B1 to hepatic macromolecules.
    Loury DN; Hsieh DP
    J Toxicol Environ Health; 1984; 13(4-6):575-87. PubMed ID: 6436500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aflatoxin B1-2,3-oxide: evidence for its formation in rat liver in vivo and by human liver microsomes in vitro.
    Swenson DH; Miller EC; Miller JA
    Biochem Biophys Res Commun; 1974 Oct; 60(3):1036-43. PubMed ID: 4429559
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of phenobarbital pretreatment on the metabolism and toxicokinetics of aflatoxin B1 in the rhesus monkey.
    Wong ZA; Wei CI; Rice DW; Hsieh DP
    Toxicol Appl Pharmacol; 1981 Sep; 60(3):387-97. PubMed ID: 6794183
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative and qualitative characterization of aflatoxin B1 adducts formed in vivo within the ribosomal RNA genes of rat liver DNA.
    Irvin TR; Wogan GN
    Cancer Res; 1985 Aug; 45(8):3497-502. PubMed ID: 3926300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linear dose-response curve for the hepatic macromolecular binding of aflatoxin B1 in rats at very low exposures.
    Appleton BS; Goetchius MP; Campbell TC
    Cancer Res; 1982 Sep; 42(9):3659-62. PubMed ID: 6179606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of phenobarbital on the biliary excretion of aflatoxin P1-glucuronide and aflatoxin B1-S-glutathione in the rat.
    Holeski CJ; Eaton DL; Monroe DH; Bellamy GM
    Xenobiotica; 1987 Feb; 17(2):139-53. PubMed ID: 3105186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced nicotinamide adenine dinucleotide phosphate-dependent formation of 2,3-dihydro-2,3-dihydroxyaflatoxin B1 from aflatoxin B1 by hepatic microsomes.
    Lin JK; Kennan KA; Miller EC; Miller JA
    Cancer Res; 1978 Aug; 38(8):2424-8. PubMed ID: 27299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.